Asahi Kasei (JP:3407) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Asahi Kasei Corp. has initiated a tender offer for Calliditas Therapeutics AB shares at SEK 208 each, aiming to make Calliditas a wholly owned subsidiary upon successful completion. The offer, starting on July 18, 2024, will run until August 30, 2024, with a potential extension if conditions are not met.
For further insights into JP:3407 stock, check out TipRanks’ Stock Analysis page.